MUC17 and inflammatory bowel disease: Subsequent staining of biopsies analyzed by glycocalyx permeability assay for MUC17 surface staining showed that non-IBD samples had a significantly higher relative MUC17 surface expression than CD samples (1.26 ± 0.51 versus 0.33 ± 0.07) (Supplemental Figure 1, B and C).